Tetra Tech Q2 Results Validate Guidance, But USAID Hole Remains

What happened

Tetra Tech reported Q2 FY2026 results with net revenue and adjusted EPS within the guided ranges, reflecting steady execution despite the structural loss of USAID contracts. The company also raised its full-year guidance, signaling confidence that defense, water, and commercial work are gradually filling the gap. However, adjusted EBITDA margin expansion was modest, and backlog ex-USAID has not yet shown accelerating growth. On the call, management highlighted continued strength in U.K. water and U.S. defense but acknowledged that disaster-related revenue remained depressed. Overall, the quarter met expectations but did not provide the clear inflection point needed to justify re-rating at current multiples.

Implication

The quarter confirms that Tetra Tech can deliver mid-single-digit growth ex-USAID, but the pace of margin expansion and backlog replenishment is insufficient to de-risk the structural revenue loss. Investors should monitor next quarter's book-to-bill and ex-USAID net revenue growth for evidence of acceleration. Until then, the current ~22x forward P/E offers limited margin of safety given ongoing legal overhang and EPA funding uncertainty.

Thesis delta

The Q2 print did not materially alter the investment thesis. The company is executing on its plan to backfill USAID via defense and water contracts, but the pace is in line with expectations, not accelerating. The 'wait' rating remains justified; the key catalysts remain a pullback to $34 or two consecutive quarters of >6% ex-USAID net revenue growth with margin expansion.